Simponi was first approved in 2009 and treats a variety of inflammatory conditions including rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis, among others. Simponi is an ...

Rudwaleit and colleagues reported the first systematic analysis of the parameters correlated with clinical responses to anti-TNF therapy in active ankylosing spondylitis patients ... such as CRP and ...

It eventually led to Still being diagnosed with ATTR amyloidosis, a rare genetic condition that causes heart problems, neuropathy, and ligament and tendon troubles. Since his diagnosis in ...

Amyloidosis occurs due to a buildup of amyloid proteins in the body. Along with treatment, complementary therapy can help with symptoms. Some examples include movements, such as yoga, sleep ...

They also say that their graphene grid method could be used to determine the structures of other small and unstable proteins -- including the amyloid-beta peptide that builds up in the brain in ...

Via brain scans, Llibre-Guerra and his team observed that while Whitney had high levels of amyloid protein in his brain, he only had a localized concentration of the protein tau. Tau build-up in ...

Two main protein structures are associated with Alzheimer’s disease: amyloid-beta plaques and neurofibrillary tangles (NFTs). Amyloid-beta: As Alzheimer’s disease develops, amyloid precursor ...

About half of people with ITP say the condition affects their emotional and psychological health, and about one-third of them say it causes them to feel self-conscious about their appearance ...

Ankylosing spondylitis is a chronic rheumatic inflammatory disease. Before the advent of biologic disease-modifying antirheumatic drugs, treatment was often ineffective, and severe ankylosing ...

Researchers discovered higher levels of tau and amyloid beta — both hallmarks of Alzheimer’s in the brain — in people who took longer to enter REM sleep, when dreaming occurs. Good sleep ...

The global in vitro diagnostics market size was reached at USD 83.41 billion in 2024 and is expected to expand around USD 129.14 billion by 2033, with a CAGR of 4.97% from 2024 to 2033. The market is ...